Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-19-000018
Filing Date
2019-01-25
Accepted
2019-01-25 21:02:03
Documents
1
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154846810628698.html 4  
1 FORM 4 wf-form4_154846810628698.xml 4 6611
  Complete submission text file 0001479290-19-000018.txt   7918
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Browne L Daniel (Reporting) CIK: 0001597583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 19543720